Freakonomics Radio cover image

433. How Are Psychedelics and Other Party Drugs Changing Psychiatry?

Freakonomics Radio

00:00

Ketamine and Psychedelics in Mental Health Treatment

This chapter examines the rise of ketamine clinics as a novel approach to treating depression, highlighting concerns about addiction and long-term dependence. It also discusses the role of psychedelics, including MDMA and CBD, in mental health therapy, addressing the balance between symptom management and deeper psychological healing. The conversation further emphasizes the importance of equitable access to these treatments and the need for continued research into their efficacy and safety.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app